De Novo device
Companion
Lgch, Inc. · Physiological Signal Based Seizure Monitoring System (POS, Class II) · First FDA decision Feb 16, 2017, newest Feb 16, 2017Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
De Novo pathway
Device trials
67
Naming "Companion"
MAUDE reports
931
Brand "Companion", since 2015
PubMed studies
22,735
Mentioning "Companion"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Companion
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- CompanionNew device typeDe Novo
DEN140033 · Decided Feb 16, 2017 · 829 days after receipt
Device type: Physiological Signal Based Seizure Monitoring System (POS) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Companion", any status and sponsor, newest update first.
- Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorPivotal-lookingRecruiting
OSE ImmunotherapeuticsNot on our public-company list
NCT06472245 · 363 participants (planned) · Start Dec 3, 2024 · Primary completion May 1, 2028
Device: NGS HLAA2 assay · For: Patients With Non-Small Cell Lung Cancer
Sites: Beverly Hills, California; Encino, California; Los Angeles, California · 207 sites in all
Meta Platforms Technologies LLCNot on our public-company list
NCT07922187 · 43 participants · Start Oct 20, 2026 · Primary completion Oct 28, 2026
Device: Hearing Enhancement · For: Hearing
Sites: Menlo Park, California
Affiliated Hospital of Nantong UniversityAcademic, hospital or other
NCT07908303 · 5,000 participants (planned) · Start Dec 1, 2026 · Primary completion Dec 1, 2028
Device: Huawei HAY20 · For: Stroke; Ischemic Stroke; Recurrent Stroke and 3 more
Sites: Nantong, China
64 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Companion", and for the whole product code for context.
This brand
931 reports: 865 malfunction, 54 injury, 12 death
Whole product code POS
4 reports: 2 malfunction, 2 injury, 0 death
Newest reports for this brand
- Syncardia Companion 2 Driver SystemMalfunction
3003761017-2026-00205 · Received Oct 28, 2026 · Event dated Oct 12, 2026
Device type: Artificial Heart (LOZ)
Device problem as coded: Loose or Intermittent Connection; Noise, Audible
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SynCardia Companion 2 DriverMalfunction
3003761017-2026-00114 · Received Oct 21, 2026 · Event dated Feb 10, 2026
Device type: Artificial Heart (LOZ)
Device problem as coded: Audible Prompt/Feedback Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SynCardia Companion 2 DriverMalfunction
3003761017-2026-00146 · Received Oct 21, 2026 · Event dated Dec 13, 2023
Device type: Artificial Heart (LOZ)
Device problem as coded: Battery Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Companion"[tiab]. The summary above synthesizes these.
- The benefits of human-companion animal interaction: a review.
Barker SB, Wolen AR · J Vet Med Educ · 2008Review
- Companion Animal Death.
Reisbig AMJ, Hafen M, Siqueira Drake AA, et al. · Omega (Westport) · 2017
- The influence of animals on the development of children.
Endenburg N, van Lith HA · Vet J · 2011Review
- Companion animals and human health: benefits, challenges, and the road ahead for human-animal interaction.
Friedman E, Krause-Parello CA · Rev Sci Tech · 2018Review
- Special Issue: Viral Infections in Companion Animals.
Hosie MJ, Hofmann-Lehmann R · Viruses · 2022Editorial, Introductory Journal Article
- Biomarkers of Stress in Companion Animals.
Ogi A, Gazzano A · Animals (Basel) · 2023Editorial
- Oncology drug-companion diagnostic combinations.
Jørgensen JT · Cancer Treat Res Commun · 2021
- Epigenetics and companion diagnostics: opportunities and challenges.
Tsoneva DK, Vinciguerra M · Epigenomics · 2023Editorial, Research Support, Non-U.S. Gov't
- Companion cell mediates wound-stimulated leaf-to-leaf electrical signaling.
Wu Q, Li Y, Chen M, et al. · Proc Natl Acad Sci U S A · 2024Research Support, Non-U.S. Gov't
- Companion Animal Fostering as Health Promotion: A Literature Review.
Roseveare C, Breheny M, Mansvelt J, et al. · Int J Environ Res Public Health · 2023Review, Research Support, Non-U.S. Gov't
- Miniature Companion Pig Sedation and Anesthesia.
Smith JS, Seddighi R · Vet Clin North Am Exot Anim Pract · 2022Review
- Zoonotic Dermatoses of Exotic Companion Mammals.
Dario d'Ovidio, Domenico Santoro · Vet Clin North Am Exot Anim Pract · 2023Review
Other devices of this type
Also filed under product code POS.
- EpiMonitorEmpatica S.r.l. · 510(k) 2025
- SPEAC SystemBrain Sentinel, Inc. · 510(k) 2021
- EmbraceEmpatica S.r.l. · 510(k) 2018
- Nelli (Version 7.11)Neuro Event Labs OY · 510(k) 2025
- NightWatch+ USLivassured BV · 510(k) 2025
- EpiWatch Monitoring SystemEpiwatch, Inc. · 510(k) 2025
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.